FESOTERODINE Drug Patent Profile
✉ Email this page to a colleague
When do Fesoterodine patents expire, and what generic alternatives are available?
Fesoterodine is a drug marketed by Accord Hlthcare, Actavis Labs Fl Inc, Alembic, Alkem Labs Ltd, Amneal Pharms Ny, Ani Pharms, Aurobindo Pharma, Chartwell Rx, Dr Reddys, Hetero Labs Ltd V, and Zydus Pharms. and is included in eleven NDAs.
The generic ingredient in FESOTERODINE is fesoterodine fumarate. There are fifteen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the fesoterodine fumarate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Fesoterodine
A generic version of FESOTERODINE was approved as fesoterodine fumarate by ALKEM LABS LTD on December 10th, 2015.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for FESOTERODINE?
- What are the global sales for FESOTERODINE?
- What is Average Wholesale Price for FESOTERODINE?
Summary for FESOTERODINE
| US Patents: | 0 |
| Applicants: | 11 |
| NDAs: | 11 |
| DailyMed Link: | FESOTERODINE at DailyMed |
US Patents and Regulatory Information for FESOTERODINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accord Hlthcare | FESOTERODINE FUMARATE | fesoterodine fumarate | TABLET, EXTENDED RELEASE;ORAL | 205012-001 | Jan 4, 2023 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Dr Reddys | FESOTERODINE FUMARATE | fesoterodine fumarate | TABLET, EXTENDED RELEASE;ORAL | 204975-002 | Aug 13, 2019 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Alkem Labs Ltd | FESOTERODINE FUMARATE | fesoterodine fumarate | TABLET, EXTENDED RELEASE;ORAL | 204827-001 | Dec 10, 2015 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Actavis Labs Fl Inc | FESOTERODINE FUMARATE | fesoterodine fumarate | TABLET, EXTENDED RELEASE;ORAL | 204868-002 | Jan 4, 2023 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
